Repligen Corp (NASDAQ: RGEN) has reported earnings for its second fiscal quarter (ending June 30) of $0.06 versus $0.36 for the same period a year ago. For the latest four quarters through June 30, E.P.S. were $-0.03 versus $2.49 for the same period a year ago.
Recent Price Action
On 7/30/24, Repligen Corp (NASDAQ: RGEN) stock enjoyed a major increase of 16.4%, closing at $160.59. Moreover, this advance was accompanied by exceptionally high trading volume at 284% of normal. Relative to the market the stock has been extremely weak over the last nine months but has risen 23.9% during the last week.
Current PriceTarget Research Rating
RGEN is expected to continue to be a modest Value Builder reflecting capital returns that are forecasted to exceed the cost of capital.
Repligen has a current Value Trend Rating of F (Lowest Rating). This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. Repligen has a poor Appreciation Score of 19 and a very low Power Rating of 11, resulting in the Lowest Value Trend Rating.
Rating Review
In light of this new information and very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment